Zoetis Inc. or Bausch Health Companies Inc.: Who Leads in Yearly Revenue?

Zoetis vs. Bausch Health: A Decade of Revenue Rivalry

__timestampBausch Health Companies Inc.Zoetis Inc.
Wednesday, January 1, 201482635000004785000000
Thursday, January 1, 2015104988000004765000000
Friday, January 1, 201696740000004888000000
Sunday, January 1, 201787240000005307000000
Monday, January 1, 201883800000005825000000
Tuesday, January 1, 201986010000006260000000
Wednesday, January 1, 202080270000006675000000
Friday, January 1, 202184340000007776000000
Saturday, January 1, 202281240000008080000000
Sunday, January 1, 202387570000008544000000
Monday, January 1, 20249256000000
Loading chart...

Cracking the code

Zoetis Inc. vs. Bausch Health: A Revenue Showdown

In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Zoetis Inc. and Bausch Health Companies Inc. have been vying for dominance. From 2014 to 2023, Bausch Health consistently led in revenue, peaking in 2015 with a 22% increase from the previous year. However, Zoetis has shown remarkable growth, with a 79% increase in revenue from 2014 to 2023, closing the gap significantly.

A Decade of Change

While Bausch Health's revenue fluctuated, Zoetis demonstrated steady growth, particularly from 2020 onwards, where it nearly matched Bausch Health's revenue by 2023. This trend highlights Zoetis's strategic advancements in the animal health sector, positioning it as a formidable competitor. As the industry evolves, these companies' financial trajectories will be crucial in determining future market leaders.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025